The claim
Herceptin can be a targeted therapy for breast cancer.
Original publisher’s rating
Despite the possible occurrences of adverse side effects, clinical evidence has shown that Herceptin is well-tolerated. It also has been approved as the standard treatment in treating HER2-positive cancers along with other chemotherapeutic agents due to the increased disease-free, progression-free, as well as overall survival rates of this drug.
Reviewed by Cancer Tutor ↗ ·
Read the original fact check ↗Sources and attribution
Original review: Cancer Tutor. Structured data compiled by Data Commons under CC BY 4.0. Publisher article content is subject to its own terms.
Updated